Back to Search
Start Over
Metformin suppresses HIF‐1α expression in cancer‐associated fibroblasts to prevent tumor‐stromal cross talk in breast cancer
- Source :
- The FASEB Journal. 34:10860-10870
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- The tumor microenvironment (TME) is a crucial factor in cancer progression. In breast cancer, cancer-associated fibroblasts (CAFs) and the derived stromal components have been recognized as comprising the majority of the pathological structure of the TME. In this study, we show that metformin (Met), a diabetes drug, transforms CAFs in the TME. Met disrupts tumor-stromal cross talk by preventing breast cancer cell transforming growth factor-β (TGF-β) signaling and the production of stromal-derived factor-1 (SDF-1) and interleukin-8 (IL-8) by CAFs. The suppression of bidirectional signaling between tumor cells and CAFs by Met is attributed to increased phospho-AMP kinase (p-AMPK) levels. By upregulating p-AMPK in CAFs, Met induces prolyl hydroxylases (PHDs), leading to the degradation of hypoxia-inducible factor-1α (HIF-1α) in CAFs. Moreover, interruption of HIF-1α-driven SDF-1 signaling in CAFs by Met leads to decreased breast cancer cell invasion. These findings suggest that Met may be used to target tumor-promoting signaling between CAFs and breast cancer cells in the TME.
- Subjects :
- Stromal cell
Breast Neoplasms
Biochemistry
Prolyl Hydroxylases
Breast cancer
Cancer-Associated Fibroblasts
Transforming Growth Factor beta
Cell Line, Tumor
Tumor Microenvironment
Genetics
medicine
Humans
Neoplasm Invasiveness
Molecular Biology
Tumor microenvironment
Kinase
business.industry
Adenylate Kinase
Interleukin-8
Cancer
Hypoxia-Inducible Factor 1, alpha Subunit
medicine.disease
Chemokine CXCL12
Metformin
Up-Regulation
MCF-7 Cells
Cancer research
Female
business
Signal Transduction
Biotechnology
medicine.drug
Transforming growth factor
Subjects
Details
- ISSN :
- 15306860 and 08926638
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- The FASEB Journal
- Accession number :
- edsair.doi.dedup.....087d33a2006e062d249b72817a62623a